Evan Snyder
13Patents
6h-index
19Co-inventors
63Inventor score
Filing activity: Aug 14, 1998 → May 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5958767A | Engraftable human neural stem cells | Chemistry; Metallurgy | 86 | Expired |
| US6680198B1 | Engraftable human neural stem cells | Chemistry; Metallurgy | 56 | Expired |
| US6541255B1 | Engraftable human neural stem cells | Chemistry; Metallurgy | 15 | Expired |
| US7186409B2 | Neural stem cells and use thereof for brain tumor therapy | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6528306B1 | Engraftable human neural stem cells | Chemistry; Metallurgy | 11 | Expired |
| US6749850B1 | Methods, compositions and kits for promoting recovery from damage to the central nervous system | Human Necessities | 9 | Expired |
| US9175263B2 | Methods and compositions for targeting progenitor cell lines | Chemistry; Metallurgy | 6 | Active |
| US10227561B2 | Methods and compositions for targeting progenitor cell lines | Chemistry; Metallurgy | 5 | Active |
| US7655224B2 | Neural stem cells and use thereof for brain tumor therapy | Emerging Cross-Sectional Technologies | 3 | Active |
| US8071378B2 | ZNF206: regulator of embryonic stem cell self-renewal and pluripotency | Chemistry; Metallurgy | 1 | Active |
| US7465582B1 | Nurr-1 induction of a dopaminergic neuronal fate in a neural stem cell or neural progenitor cell in vitro | Physics | 1 | Expired |
| US7393526B2 | Systemic gene delivery vehicles for the treatment of tumors | Human Necessities | 0 | Expired |
| US12223643B2 | Machine-learning system for diagnosing disorders and diseases and determining drug responsiveness | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.